Performa LTD (Us), LLC Teva Pharmaceutical Industries LTD Transaction History

Performa LTD (Us), LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$12.78 - $17.4 $2,556 - $3,479	-200 Reduced 34.19%	385 $6,000
Q3 2022 Nov 09, 2022	SELL	$6.86 - $11.95 $1,474 - $2,569	-215 Reduced 26.88%	585 $5,000
Q2 2022 Aug 02, 2022	BUY	$7.38 - $10.4 $369 - $520	50 Added 6.67%	800 $6,000
Q1 2022 May 13, 2022	SELL	$7.33 - $9.39 $2,199 - $2,817	-300 Reduced 28.57%	750 $7,000
Q4 2021 Jan 31, 2022	BUY	$7.9 - $10.19 $5,135 - $6,623	650 Added 162.5%	1,050 $8,000
Q3 2021 Oct 28, 2021	BUY	$8.38 - $10.18 $2,514 - $3,054	300 Added 300.0%	400 $4,000
Q2 2021 Jul 28, 2021	BUY	$9.9 - $11.56 $990 - $1,156	100 New	100 $1,000
Q2 2021 Jul 27, 2021	SELL	$9.9 - $11.56 $990 - $1,156	-100 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$10.34 - $12.81 $517 - $640	-50 Reduced 33.33%	100 $1,000
Q4 2020 Jan 27, 2021	BUY	$8.61 - $11.04 $1,291 - $1,655	150 New	150 $1,000
Q1 2020 Apr 23, 2020	SELL	$6.69 - $13.45 $100,350 - $201,750	-15,000 Closed	0 $0
Q4 2019 Jan 30, 2020	SELL	$6.53 - $10.72 $21,549 - $35,376	-3,300 Reduced 18.03%	15,000 $147,000
Q2 2019 Jul 31, 2019	BUY	$8.12 - $15.72 $148,596 - $287,676	18,300 New	18,300 $169,000

626

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $23.2B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Performa LTD (Us), LLC, based on Form 13F filings with the SEC.

Stay updated on Performa LTD (Us), LLC with notifications on news.